Tyler Bartholomew, Ph.D., is an associate professor in the Division of Health Services Research and Policy in the Department of Public Health Sciences at the University of Miami Miller School of Medicine. He is co-principal investigator of the IDEA Lab, which works to implement, disseminate, and evaluate programs that improve the health of people who use drugs.
His research focuses on the infectious complications of substance use, particularly among people who inject drugs, using data-driven approaches to improve health services, systems, and policy implementation. He led research and evaluation efforts for the IDEA Miami Syringe Services Program, the first legal syringe services program in Florida. This work contributed to statewide legislation enacted in 2019 allowing all Florida counties to implement syringe services programs.
Bartholomew’s research has been funded by the National Institutes of Health, the Centers for Disease Control and Prevention, and Gilead Sciences and has resulted in more than 50 publications in journals including the American Journal of Public Health, Clinical Infectious Diseases, Addiction, and the International Journal of Drug Policy. He is an investigator in the Clinical Trials Network Florida Node Alliance, funded by the National Institute on Drug Abuse.
He also supports statewide implementation of syringe services programs through a partnership with the Florida Harm Reduction Collective, applying community-driven implementation science to improve program adoption, implementation, and sustainability. He serves on the organization’s board of directors.
Bartholomew earned his Ph.D. in prevention science from the University of Miami.